51167-121 : Alyftrek Oral Tablet, Film Coated
| NDC: | 51167-121 |
| Labeler: | Vertex Pharmaceuticals Incorporated |
| Product Type: | Human Prescription Drug |
| Drug Name: | Alyftrek |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA218730 |
| Rev. Date: |
NDC Package Codes:
- 51167-121-01: 4 BLISTER PACK IN 1 CARTON (51167‑121‑01) / 14 TABLET, FILM COATED IN 1 BLISTER PACK
Active Ingredients:
- Deutivacaftor
- Tezacaftor
- Vanzacaftor
Dosage Strength:
- 125 mg
- 50 mg
- 10 mg
Pharmaceutical Classes:
- Breast Cancer Resistance Protein Inhibitors [MoA]
- Chloride Channel Activation Potentiators [MoA]
- Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
- Cytochrome P450 2C9 Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 51167-135 Alyftrek Oral Tablet, Film Coated by Vertex Pharmaceuticals Incorporated
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 51167-113Next: 51167-122 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.